ResearcherEast China Normal UniversityNo recent work listed

Haijun Gu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1613-7063; OpenAlex author ID A5037249308. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2022: 1 paper

Papers 1

Discovery of 1,5-diaryl-1,2,4-triazole derivatives as myoferlin inhibitors and their antitumor effects in pancreatic cancer. Co-author DOI 10.4155/fmc-2022-0168 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Peng He · 1 shared paper, 2022 · strength 0.16
- Paper Discovery of 1,5-diaryl-1,2,4-triazole derivatives as myoferlin inhibitors and their antitumor effects in pancreatic ca… DOI 10.4155/fmc-2022-0168 ↗
Yunqi Li · 1 shared paper, 2022 · strength 0.16
- Paper Discovery of 1,5-diaryl-1,2,4-triazole derivatives as myoferlin inhibitors and their antitumor effects in pancreatic ca… DOI 10.4155/fmc-2022-0168 ↗
Yihua Chen · 1 shared paper, 2022 · strength 0.16
- Paper Discovery of 1,5-diaryl-1,2,4-triazole derivatives as myoferlin inhibitors and their antitumor effects in pancreatic ca… DOI 10.4155/fmc-2022-0168 ↗
Zhengfang Yi · 1 shared paper, 2022 · strength 0.16
- Paper Discovery of 1,5-diaryl-1,2,4-triazole derivatives as myoferlin inhibitors and their antitumor effects in pancreatic ca… DOI 10.4155/fmc-2022-0168 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.